JP2002537225A - 置換ベンゾ［ｄｅ］イソキノリン−１，３−ジオン類 - Google Patents
置換ベンゾ［ｄｅ］イソキノリン−１，３−ジオン類Info
- Publication number
- JP2002537225A JP2002537225A JP2000585219A JP2000585219A JP2002537225A JP 2002537225 A JP2002537225 A JP 2002537225A JP 2000585219 A JP2000585219 A JP 2000585219A JP 2000585219 A JP2000585219 A JP 2000585219A JP 2002537225 A JP2002537225 A JP 2002537225A
- Authority
- JP
- Japan
- Prior art keywords
- phenyl
- benzo
- het
- formula
- embedded image
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/06—Ring systems of three rings
- C07D221/14—Aza-phenalenes, e.g. 1,8-naphthalimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19941398A | 1998-11-25 | 1998-11-25 | |
| US39878399A | 1999-09-20 | 1999-09-20 | |
| US09/199,413 | 1999-09-20 | ||
| US09/398,783 | 1999-09-20 | ||
| PCT/EP1999/008561 WO2000032577A2 (en) | 1998-11-25 | 1999-11-09 | Substituted benzo[de]isoquinoline-1,3-diones |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2002537225A true JP2002537225A (ja) | 2002-11-05 |
Family
ID=26894745
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000585219A Pending JP2002537225A (ja) | 1998-11-25 | 1999-11-09 | 置換ベンゾ［ｄｅ］イソキノリン−１，３−ジオン類 |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP1144381A2 (cs) |
| JP (1) | JP2002537225A (cs) |
| KR (1) | KR20010080569A (cs) |
| CN (1) | CN1330638A (cs) |
| AU (1) | AU760136B2 (cs) |
| BR (1) | BR9915648A (cs) |
| CA (1) | CA2352045A1 (cs) |
| CZ (1) | CZ20011782A3 (cs) |
| HU (1) | HUP0104520A3 (cs) |
| ID (1) | ID28982A (cs) |
| NO (1) | NO20012544L (cs) |
| PL (1) | PL348204A1 (cs) |
| SK (1) | SK7022001A3 (cs) |
| TW (1) | TW473474B (cs) |
| WO (1) | WO2000032577A2 (cs) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003321452A (ja) * | 2002-04-22 | 2003-11-11 | Xanthus Life Sciences Inc | アモナフィド塩 |
| JP2017528524A (ja) * | 2014-09-19 | 2017-09-28 | イェン−タ ル | ベンゾ複素環化合物およびその用途 |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6429212B1 (en) * | 1996-08-16 | 2002-08-06 | Ishihara Sangyo Kaisha Ltd. | Medicinal composition |
| EP1088821A1 (en) * | 1999-09-28 | 2001-04-04 | Applied Research Systems ARS Holding N.V. | Pharmaceutically active sulfonamide derivatives |
| WO2003007931A1 (fr) * | 2001-06-08 | 2003-01-30 | Institute Of Medicinal Molecular Design. Inc. | Derives de sulfonamide |
| US8097725B2 (en) | 2004-12-03 | 2012-01-17 | Roche Diagnostics Operations, Inc. | Luminescent indicator dye and optical sensor |
| FR2915685A1 (fr) * | 2007-05-02 | 2008-11-07 | Thales Sa | Compose fluorescent a l'etat solide dans l'eau,procede de synthese et utilisation dans des capteurs |
| EP2970227B1 (en) | 2013-03-15 | 2018-01-10 | Alumend, LLC | Compositions and methods of using the compositions for plaque softening |
| US9662324B2 (en) | 2013-05-01 | 2017-05-30 | Academia Sinica | Methods and compositions for treating β-thalassemia and sickle cell disease |
| CN103450176B (zh) * | 2013-08-15 | 2016-07-06 | 大连理工大学 | 一类含2-（4-氨基苯基）苯并噻唑萘酰亚胺化合物及其应用 |
| CN106905237B (zh) * | 2017-02-08 | 2019-05-14 | 上海师范大学 | 一种pH和乏氧双响应定位肿瘤细胞的萘酰亚胺类比率荧光探针及其合成方法 |
| CN110283123B (zh) * | 2019-07-08 | 2022-06-17 | 桂林医学院 | 4-对甲苯磺酰基哌嗪-3-硝基-1,8-萘酰亚胺衍生物及其合成方法和应用 |
| CN110272388B (zh) * | 2019-07-08 | 2022-06-17 | 桂林医学院 | 4-二硫代甲酸哌嗪-3-硝基-1,8-萘酰亚胺衍生物及其合成方法和应用 |
| CN110407865B (zh) * | 2019-08-02 | 2022-04-15 | 山东师范大学 | 基于苯磺酰胺结构的式（i）化合物及其制备方法与应用 |
| CN111518075B (zh) * | 2020-04-17 | 2023-03-28 | 西南大学 | 萘酰亚胺哌嗪三唑类化合物及其制备方法和应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2423546C2 (de) * | 1974-05-15 | 1983-01-27 | Hoechst Ag, 6000 Frankfurt | Verfahren zur Herstellung von 4-Amino-1,8- naphthalsäure-N-arylimid-Verbindungen |
| ES459497A1 (es) * | 1977-06-04 | 1978-04-16 | Made Labor Sa | Un metodo para la preparacion industrial de naftalimidas y sus derivados. |
| DE3635711A1 (de) * | 1986-10-21 | 1988-04-28 | Knoll Ag | 5-nitrobenzo(de)isochinolin-1,3-dione, ihre herstellung und verwendung |
| JP2001503397A (ja) * | 1996-10-21 | 2001-03-13 | アレリックス バイオファーマシューティカルズ インコーポレイテッド | ニューロトロフィンアンタゴニスト組成物 |
| WO1998018764A1 (de) * | 1996-10-28 | 1998-05-07 | Merck Patent Gmbh | Dihydrobenzoanthracenone, -pyrimidinone oder dihydronaphthochinolinone |
-
1999
- 1999-11-09 BR BR9915648-2A patent/BR9915648A/pt not_active IP Right Cessation
- 1999-11-09 ID IDW00200101392A patent/ID28982A/id unknown
- 1999-11-09 SK SK702-2001A patent/SK7022001A3/sk unknown
- 1999-11-09 CN CN99813687A patent/CN1330638A/zh active Pending
- 1999-11-09 CZ CZ20011782A patent/CZ20011782A3/cs unknown
- 1999-11-09 WO PCT/EP1999/008561 patent/WO2000032577A2/en not_active Application Discontinuation
- 1999-11-09 AU AU26603/00A patent/AU760136B2/en not_active Ceased
- 1999-11-09 PL PL99348204A patent/PL348204A1/xx unknown
- 1999-11-09 HU HU0104520A patent/HUP0104520A3/hu unknown
- 1999-11-09 CA CA002352045A patent/CA2352045A1/en not_active Abandoned
- 1999-11-09 KR KR1020017006547A patent/KR20010080569A/ko not_active Application Discontinuation
- 1999-11-09 JP JP2000585219A patent/JP2002537225A/ja active Pending
- 1999-11-09 EP EP99968783A patent/EP1144381A2/en not_active Withdrawn
- 1999-11-24 TW TW088120540A patent/TW473474B/zh not_active IP Right Cessation
-
2001
- 2001-05-23 NO NO20012544A patent/NO20012544L/no not_active Application Discontinuation
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003321452A (ja) * | 2002-04-22 | 2003-11-11 | Xanthus Life Sciences Inc | アモナフィド塩 |
| JP4630518B2 (ja) * | 2002-04-22 | 2011-02-09 | アンティソーマ・リサーチ・リミテッド | アモナフィド塩 |
| JP2017528524A (ja) * | 2014-09-19 | 2017-09-28 | イェン−タ ル | ベンゾ複素環化合物およびその用途 |
Also Published As
| Publication number | Publication date |
|---|---|
| ID28982A (id) | 2001-07-19 |
| CA2352045A1 (en) | 2000-06-08 |
| HUP0104520A3 (en) | 2002-10-28 |
| KR20010080569A (ko) | 2001-08-22 |
| NO20012544D0 (no) | 2001-05-23 |
| AU2660300A (en) | 2000-06-19 |
| HUP0104520A2 (hu) | 2002-04-29 |
| TW473474B (en) | 2002-01-21 |
| SK7022001A3 (en) | 2002-09-10 |
| EP1144381A2 (en) | 2001-10-17 |
| PL348204A1 (en) | 2002-05-06 |
| WO2000032577A3 (en) | 2000-09-21 |
| NO20012544L (no) | 2001-05-23 |
| WO2000032577A2 (en) | 2000-06-08 |
| BR9915648A (pt) | 2001-08-14 |
| CN1330638A (zh) | 2002-01-09 |
| CZ20011782A3 (cs) | 2001-09-12 |
| AU760136B2 (en) | 2003-05-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5478844A (en) | Method of using aminocoumaran derivatives for treating cerebrovascular diseases | |
| JP3176365B2 (ja) | ベンゼンスルホンアミド誘導体 | |
| KR100837420B1 (ko) | 5-히드록시-인돌-3-카르복시산에스테르 유도체 및 이의용도 | |
| JP2002537225A (ja) | 置換ベンゾ［ｄｅ］イソキノリン−１，３−ジオン類 | |
| JPH09501404A (ja) | 新規化合物 | |
| JP2002516325A (ja) | 新規な置換イミダゾール化合物 | |
| JP2001526220A (ja) | 置換複素環式尿素を用いたｒａｆキナーゼの阻害 | |
| JP4023841B2 (ja) | ヘテロサイクリル−ベンゾイルグアニジン化合物 | |
| JPH07267926A (ja) | ４−アミノ−１−ピペリジルベンゾイルグアニジン | |
| EA006300B1 (ru) | Производные фталазинона | |
| JP2002530400A (ja) | インテグリン阻害剤としてのプロパン酸誘導体 | |
| JP2000143635A (ja) | 血管新生阻害剤 | |
| WO2001058893A2 (de) | Indol-3-yl-derivate und deren verwendung als integrin-inhibitoren | |
| JP2004523475A (ja) | タンパク質Ｊｕｎキナーゼのインヒビターとしての医薬的活性ベンズスルホンアミド誘導体 | |
| JP2002530379A (ja) | 置換ベンゾ［ｄｅ］イソキノリン−１，３−ジオン類 | |
| EP0546102B1 (en) | Tropolone derivatives and pharmaceutical composition thereof for preventing and treating ischemic diseases | |
| JPH09501405A (ja) | 抗不整脈用ｎ−置換３−ベンズアゼピンまたはイソキノリン | |
| KR100227953B1 (ko) | 신규한 3,4-디하이드로이소퀴놀린 유도체, 및 카보사이클 및 헤테로사이클 융합된 디하이드로피리딘 및 이들을 함유하는 약제학적 제제 | |
| US5576327A (en) | Treatment of heart rhythym disorders by administration of 3-phenylsulfonyl-3, 7-diazabicyclo[3.3.1]nonane compounds | |
| AU644605B2 (en) | Pyridone nitriles useful in treating cardiovascular disease | |
| JPH0940649A (ja) | エンドセリン受容体拮抗物質 | |
| DE60113300T2 (de) | Piperazinylcarbonylchinoline und isochinoline | |
| WO2003082263A1 (en) | Sulfamic acids as inhibitors of human cytoplasmic protein tyrosine phosphatases | |
| JPH03291277A (ja) | アミノピリミジン誘導体、その製造方法、該誘導体を含有する心臓血管疾病を治療するための医薬組成物および中間生成物 | |
| JP2747013B2 (ja) | ブテン酸又はプロペン酸誘導体 |